Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 29

The DOI matches its Crossref record.

An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy

Lee, Vivian K., Lee, Taewoo, Ghosh, Amrit, Saha, Tanmoy, Bais, Manish V., Bharani, Kala Kumar, Chag, Milan, Parikh, Keyur, Bhatt, Parloop, Namgung, Bumseok, Venkataramanan, Geethapriya, Agrawal, Animesh, Sonaje, Kiran, Mavely, Leo, Sengupta, Shiladitya, Mashelkar, Raghunath Anant, Jang, Hae Lin · 2024 · Proceedings of the National Academy of Sciences

Abstract

Hemostatic devices are critical for managing emergent severe bleeding. With the increased use of anticoagulant therapy, there is a need for next-generation hemostats. We rationalized that a hemostat with an architecture designed to increase contact with blood, and engineered from a material that activates a distinct and undrugged coagulation pathway can address the emerging need. Inspired by lung alveolar architecture, here, we describe the engineering of a next-generation single-phase chitosan hemostat with a tortuous spherical microporous design that enables rapid blood absorption and concentrated platelets and fibrin microthrombi in localized regions, a phenomenon less observed with other classical hemostats without structural optimization. The interaction between blood components and the porous hemostat was further amplified based on the charged surface of chitosan. Contrary to the dogma that chitosan does not directly affect physiological clotting mechanism, the hemostat induced coagulation via a direct activation of platelet Toll-like receptor 2. Our engineered porous hemostat effectively stopped the bleeding from murine liver wounds, swine liver and carotid artery injuries, and the human radial artery puncture site within a few minutes with significantly reduced blood loss, even under the anticoagulant treatment. The integration of engineering design principles with an understanding of the molecular mechanisms can lead to hemostats with improved functions to address emerging medical needs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2316170121

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 64

  1. 10.1007/s00134-019-05560-x · DOI
  2. E. R. Donley, J. W. Loyd, Hemorrhage Control (StatPearls Publishing, 2018).
  3. 10.1111/jth.13697 · DOI
  4. 10.1182/blood-2007-10-120543 · DOI · Paper page
  5. 10.1080/10903120601021176 · doi:10.1080/10903120601021176
  6. 10.1016/j.thromres.2023.03.010 · DOI
  7. H. T. Peng, Hemostatic agents for prehospital hemorrhage control: A narrative review. Mil. Med. Res. 7, 1–18 (2020).
  8. 10.7205/MILMED.169.9.716 · DOI
  9. 10.7205/MILMED-D-13-00199 · DOI · Paper page
  10. 10.1136/emermed-2012-201581 · DOI
  11. 10.1073/pnas.73.8.2554 · DOI · Paper page
  12. 10.1007/s10856-007-3243-y · DOI
  13. 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P · DOI · Paper page
  14. 10.1097/TA.0b013e3181c97ef1 · doi:10.1097/ta.0b013e3181c97ef1
  15. 10.1088/1748-6041/10/1/015014 · doi:10.1088/1748-6041/10/1/015014
  16. 10.21037/atm-20-7160 · DOI
  17. 10.1038/nm.1955 · DOI · Paper page
  18. 10.1182/blood-2006-04-011551 · DOI · Paper page
  19. 10.1002/adma.201908249 · DOI · Paper page
  20. 10.1016/j.actbio.2020.07.043 · DOI
  21. 10.1038/s41467-021-24972-2 · DOI · Paper page
  22. 10.1016/j.coche.2021.100746 · doi:10.1016/j.coche.2021.100746
  23. 10.1016/j.carbpol.2011.01.029 · DOI
  24. 10.1016/j.actbio.2018.11.005 · doi:10.1016/j.actbio.2018.11.005
  25. 10.1007/978-1-4615-5303-8_7 · doi:10.1007/978-1-4615-5303-8_7
  26. 10.1016/S0021-9258(19)49614-2 · doi:10.1016/s0021-9258(19)49614-2
  27. 10.1152/physrev.00020.2015 · DOI · Paper page
  28. 10.1111/j.1365-2141.2008.07506.x · DOI
  29. 10.1182/bloodadvances.2019000182 · DOI
  30. 10.4070/kcj.2012.42.5.295 · DOI
  31. 10.1111/jth.13395 · doi:10.1111/jth.13395
  32. N. Khan, A. D. Farooq, B. Sadek, Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists. Drug Des. Devel. Ther. 9, 3497 (2015).
  33. 10.1016/j.cellsig.2013.11.011 · DOI
  34. 10.5812/traumamon.26023 · doi:10.5812/traumamon.26023
  35. 10.1371/journal.pone.0169731 · DOI · Paper page
  36. 10.3390/polym11111906 · DOI · Paper page
  37. 10.3389/fbioe.2020.627351 · DOI
  38. 10.1016/j.surg.2016.09.022 · DOI
  39. 10.1080/09537104.2020.1719056 · DOI
  40. 10.1097/01.TA.0000075336.92129.27 · DOI
  41. 10.1186/s12893-020-00874-w · doi:10.1186/s12893-020-00874-w
  42. 10.7326/M15-1277 · DOI
  43. 10.1186/CVM-2-3-129 · DOI
  44. 10.3325/cmj.2014.55.609 · doi:10.3325/cmj.2014.55.609
  45. 10.15441/ceem.14.018 · DOI
  46. 10.1055/s-2005-858328 · DOI
  47. 10.1002/ccd.22615 · doi:10.1002/ccd.22615
  48. 10.1097/JCN.0000000000000115 · DOI
  49. 10.1016/j.carrev.2018.11.026 · DOI · Paper page
  50. J. S. Roberts, J. Niu, J. A. Pastor-Cervantes, Comparison of hemostasis times with a kaolin-based hemostatic pad (QuikClot radial) vs mechanical compression (TR band) following transradial access: A pilot prospective study. J. Invasive Cardiol. 29, 328–334 (2017).
  51. 10.1097/00005373-200301000-00023 · DOI · Paper page
  52. 10.1097/TA.0b013e318248baa1 · doi:10.1097/ta.0b013e318248baa1
  53. 10.1590/1980-5373-MR-2015-0793 · DOI
  54. 10.1016/j.carbpol.2017.12.066 · DOI
  55. 10.1161/ATVBAHA.112.253765 · doi:10.1161/atvbaha.112.253765
  56. 10.1371/journal.pone.0055466 · doi:10.1371/journal.pone.0055466
  57. 10.15252/embr.201846065 · DOI
  58. 10.4244/EIJV6I9A192 · doi:10.4244/eijv6i9a192
  59. 10.1038/nrd3203 · DOI · Paper page
  60. 10.1002/jctb.2495 · DOI · Paper page
  61. 10.1016/j.ijbiomac.2018.11.045 · DOI · Paper page
  62. 10.1002/adhm.202000951 · DOI
  63. 10.1021/acsnano.5b01052 · DOI
  64. 10.1371/journal.pone.0225007 · DOI

Cited by

See all 29

Metadata

Authors
Lee, V. K., Lee, T., Ghosh, A., Saha, T., Bais, M. V., Bharani, K. K., Chag, M., Parikh, K., Bhatt, P., Namgung, B., Venkataramanan, G., Agrawal, A., Sonaje, K., Mavely, L., Sengupta, S., Mashelkar, R. A., & Jang, H. L.
Affiliations
  • Center for Engineered Therapeutics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
  • Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, P. V. Narasimha Rao Telangana Veterinary University, Hyderabad 500030, India
  • Care Institute of Medical Sciences, Ahmedabad 380060, India
  • Axio Biosolutions Private Limited, Ahmedabad 382220, India
  • National Chemical Laboratories, Pune 411021, India
Venue
Proceedings of the National Academy of Sciences
Published
2024-01-22
Volume
121
Issue
5
ISSN
  • 0027-8424
  • 1091-6490
Cited by
29
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy. https://app.cochat.ai/papers/10.1073/pnas.2316170121
The paper
Lee, V. K., Lee, T., Ghosh, A., Saha, T., Bais, M. V., Bharani, K. K., Chag, M., Parikh, K., Bhatt, P., Namgung, B., Venkataramanan, G., Agrawal, A., Sonaje, K., Mavely, L., Sengupta, S., Mashelkar, R. A., & Jang, H. L. (2024). An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2316170121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.